Research and Markets (http://www.researchandmarkets.com/research/4ddfa0/the_outlook_for_ph) has announced the addition of the "The Outlook for Pharmaceuticals in Latin America" report to their offering.
The region needs to increase drug access, in spite of intensifying cost-containment measures. Therefore, attractive opportunities for (bio)pharmaceutical producers exist in Latin America. Brazil has the largest pharmaceutical market. Strong economic performance will fuel pharmacy sales growth in the forecast period. Mexico is the second leading market. Recent regulatory developments will create further market opportunities in the country, particularly for generic producers in both the private and public sectors. In Argentina, the pharmaceutical industry is expected to perform well in the coming years, with strong growth in production, sales, exports and employment. Pharmaceutical companies, however, are encouraged to act in smaller Latin American markets to maximise their full regional sales potential.
Generics consumption in Latin America is low, with the exception of Brazil which has a dynamic bioequivalent generic sector. In the last two years, foreign producers have penetrated what, until then, had been considered a tough sector due to local protectionism and low prices.
These Reports Analyse the Issues:
The Outlook for Pharmaceuticals in Latin America is a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection, and prices include 4 completely updated reports sent quarterly, together with a comprehensive statistical appendix. There are over 60 markets covered in the worldwide series.
Key Topics Covered:
BACKGROUND DATA Population data, including growth trends and age structure Demographic indicators detailing principal causes of death and morbidity
ACCESSING THE PHARMA MARKET
For more information visit http://www.researchandmarkets.com/research/4ddfa0/the_outlook_for_ph
Source: Espicom Business Intelligence LtdBusiness Wire
Last updated on: 16/03/2012